Details of issuance or disposal
Report on the Completion of the Allocation of Funds Raised Through the Exercise of Stock Acquisition Rights with an Exercise Price Adjustment Clause
Total funds raised: ¥1,993 million; estimated net proceeds after expenses: Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Report on the Completion of the Allocation of Funds Raised Through the Exercise of Stock Acquisition Rights with an Exercise Price Adjustment Clause |
| Amount of funds to be raised | Total funds raised: ¥1,993 million; estimated net proceeds after expenses: Not disclosed |
| Specific use of funds | Details R&D Funding / Amount ¥1,387 million / Scheduled timing of expenditures September 2026, Details Working capital / Amount ¥606 million / Scheduled timing of expenditures September 2026 |
| Exercise price | Only the inclusion of an exercise price adjustment clause is stated; the initial exercise price and adjustment floor: Not disclosed |
| Most recent equity financing | Timing 5 June 2023 / Type Issuance of the 24th Series of Stock Acquisition Rights with an Exercise Price Adjustment Clause / Amount Not disclosed |
Items this document does not state (23)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.A disclosure dated 20 November 2025 stated that the Company would make a timely disclosure as soon as the allocation of the funds was completed.